Search results for "EPILEPSY"

showing 10 items of 420 documents

Benign and severe early-life seizures: a round in the first year of life

2018

Abstract Background At the onset, differentiation between abnormal non-epileptic movements, and epileptic seizures presenting in early life is difficult as is clinical diagnosis and prognostic evaluation of the various seizure disorders presenting at this age. Seizures starting in the first year of life including the neonatal period might have a favorable course, such as in infants presenting with benign familial neonatal epilepsy, febrile seizures simplex or acute symptomatic seizures. However, in some cases, the onset of seizures at birth or in the first months of life have a dramatic evolution with severe cerebral impairment. Seizure disorders starting in early life include the “epilepti…

Ohtahara syndromePediatricsmedicine.medical_specialtyEarly onset seizuresFirst year of lifeReviewEpileptic encephalopathieEpileptic encephalopathies03 medical and health sciencesEpilepsyInfantile epilepsy0302 clinical medicineDravet syndromeSeizures030225 pediatricsmedicineHumansEarly myoclonic encephalopathybusiness.industryAge FactorsInfant Newbornlcsh:RJ1-570InfantWest SyndromeSymptomatic seizureslcsh:Pediatricsmedicine.diseaseMyoclonic epilepsyEarly onset seizurebusiness030217 neurology & neurosurgeryItalian Journal of Pediatrics
researchProduct

IQSEC2-related encephalopathy in males and females: a comparative study including 37 novel patients.

2019

Variants in IQSEC2, escaping X inactivation, cause X-linked intellectual disability with frequent epilepsy in males and females. We aimed to investigate sex-specific differences.

0301 basic medicineMaleGénétique clinique[SDV]Life Sciences [q-bio]MedizinPhysiology030105 genetics & hereditySeizures/epidemiologyEpilepsyBrain Diseases/epidemiologyX-linked inheritanceIntellectual disabilityGuanine Nucleotide Exchange FactorsProtein IsoformsMissense mutationGenetics(clinical)10. No inequalityNon-U.S. Gov'tGenetics (clinical)X-linked recessive inheritanceComputingMilieux_MISCELLANEOUSBrain DiseasesSex CharacteristicsResearch Support Non-U.S. Gov'tBrainSciences bio-médicales et agricoles3. Good healthPedigreePhenotypeintellectual disabilityFemaleBrain/growth & developmentSex characteristicsGénétique moléculaireGuanine Nucleotide Exchange Factors/geneticsEncephalopathyResearch SupportX-inactivationArticle03 medical and health sciencesSeizuresProtein Isoforms/geneticsmedicineJournal ArticleIQSEC2HumansIntellectual Disability/epidemiology[SDV.GEN]Life Sciences [q-bio]/Geneticsbusiness.industryInfant NewbornisoformsCorrectionInfantmedicine.diseaseNewbornHuman genetics030104 developmental biologyMutationepilepsyHuman medicinebusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

Enhanced tonic GABAA inhibition in typical absence epilepsy

2009

The cellular mechanisms underlying typical absence seizures, which characterize various idiopathic generalized epilepsies, are not fully understood, but impaired γ-aminobutyric acid (GABA)-ergic inhibition remains an attractive hypothesis. In contrast, we show here that extrasynaptic GABAA receptor–dependent 'tonic' inhibition is increased in thalamocortical neurons from diverse genetic and pharmacological models of absence seizures. Increased tonic inhibition is due to compromised GABA uptake by the GABA transporter GAT-1 in the genetic models tested, and GAT-1 is crucial in governing seizure genesis. Extrasynaptic GABAA receptors are a requirement for seizures in two of the best character…

GABA Plasma Membrane Transport ProteinsGABA Plasma Membrane Transport ProteinsCellular pathologystargazerBiologyPharmacologytonic currentSettore BIO/09 - FisiologiaArticleGeneral Biochemistry Genetics and Molecular BiologyTonic (physiology)spike–and–wave discharge03 medical and health sciencesEpilepsy0302 clinical medicineThalamusthalamusGenetic modelmedicineAnimalsGABA transporterGABA-A Receptor AntagonistsReceptorTHIP030304 developmental biology0303 health sciencesextrasynaptic tonic current GAT–1 thalamus spike–and–wave discharge GAERS stargazer lethargic GHB THIPGABAA receptorAminobutyratesPetit mal epilepsyGeneral Medicineextrasynapticmedicine.diseaseReceptors GABA-ARats3. Good healthEpilepsy Absenceabsence epilepsy GABA electrophysiology patch clampnervous systemGAT–1GAERSbiology.proteinlethargicGHB030217 neurology & neurosurgery
researchProduct

Persistent psychogenic déjà vu: a case report.

2014

Introduction: Déjà vu is typically a transient mental state in which a novel experience feels highly familiar. Although extensively studied in relation to temporal lobe epilepsy as part of simple partial seizures, déjà vu has been less studied in other clinical populations. A recent review of temporal lobe epilepsy suggested a possible link between clinical levels of anxiety and debilitating déjà vu, indicating further research is required. Here, for the first time in the literature, we present a case study of a young man with anxiety and depersonalisation who reported experiencing persistent and debilitating déjà vu. This report therefore adds to the limited literature on the relationship …

Malemedicine.medical_specialtyCase ReportAnxietyNeuropsychological TestsTemporal lobeRecognition memoryEpilepsyYoung AdultJamais vuDepersonalizationmedicinePsychogenic diseaseHumansPsychiatryRecognition memoryMedicine(all)business.industryRecognition PsychologyGeneral MedicineDeja Vumedicine.diseaseDéjà vuCase-Control StudiesDepersonalizationDéjà vuAnxietymedicine.symptombusinessJournal of medical case reports
researchProduct

N-valproyl-L-tryptophan for CNS-targeting: synthesis, characterization and efficacy in vitro studies of a new potential antiepileptic drug.

2010

A new aminoacidic derivative of valproic acid (VPA) has been synthesized and characterized by analytical and spectral data. The rationale for the preparation of such potential antiepileptic agent is based on the observation that chemical combination of the anticonvulsant pharmacophore, VPA with essential aminoacids could afford more effective and less toxic actives. The synthesis, characterization, physico-chemical parameters functional for crossing Blood Brain Barrier of N-valproyl-L-tryptophan (4) are reported. The Log D pH7.4 (0.3) indicates that (4) is adequate to cross biological membranes. Its chemical and enzymatic stability were assessed. The experiments indicate high stability of c…

Malemedicine.medical_treatmentHippocampal formationPharmacologyIn Vitro TechniquesBlood–brain barrierSettore BIO/09 - FisiologiaHippocampuschemistry.chemical_compoundDrug StabilityIn vivoDrug DiscoverymedicineAnimalsRats WistarValproic AcidEpilepsyDipeptidesAminoacidic derivative Antiepileptic Drug CNS-Targeting Enzymatic Stability Seizure Like Events Model Valproic acidIn vitroElectrophysiological PhenomenaRatsmedicine.anatomical_structureAnticonvulsantchemistrySettore CHIM/09 - Farmaceutico Tecnologico ApplicativoAnticonvulsantsPharmacophoreDerivative (chemistry)medicine.drugMedicinal chemistry (Shariqah (United Arab Emirates))
researchProduct

Poor prognosis despite successful treatment of postanoxic generalized myoclonus.

2010

Generalized myoclonus (GM) after cardiopulmonary resuscitation (CPR) implies a poor prognosis.1 Postanoxic GM is usually classified as one type of convulsive status epilepticus,2 which is also reflected by terms like myoclonic status,3 myoclonic status epilepticus,4 or postanoxic status epilepticus.5 Antiepileptic drugs commonly used in the treatment of status epilepticus such as phenytoin or valproate, however, are ineffective in the majority of these patients.3,4,6 Reports of single patients7 and our own observations6 indicated that propofol may control GM. This prompted us to use propofol as standard treatment of postanoxic GM in 60 consecutive comatose survivors of CPR. ### Level of evi…

AdultMaleMyoclonusmedicine.medical_treatmentMyoclonic JerkStatus epilepticusEpilepsyIntensive caremedicineHumansCardiopulmonary resuscitationComaHypoxia BrainPropofolAgedAged 80 and overbusiness.industryStandard treatmentElectroencephalographyMiddle Agedmedicine.diseasePrognosisTreatment OutcomeAnesthesiaFemaleNeurology (clinical)medicine.symptomPropofolbusinessMyoclonusmedicine.drugNeurology
researchProduct

In response: Neuronal networks in epileptic encephalopathies with CSWS

2017

0301 basic medicinebusiness.industryElectroencephalographyBrain Waves03 medical and health sciences030104 developmental biology0302 clinical medicineText miningNeurologyMedicineEpilepsy GeneralizedNeurology (clinical)businessNeuroscience030217 neurology & neurosurgeryEpilepsia
researchProduct

Antiepileptogenic Effect of Subchronic Palmitoylethanolamide Treatment in a Mouse Model of Acute Epilepsy

2018

Research on the antiepileptic effects of (endo-)cannabinoids has remarkably progressed in the years following the discovery of fundamental role of the endocannabinoid (eCB) system in controlling neural excitability. Moreover, an increasing number of well-documented cases of epilepsy patients exhibiting multi-drug resistance report beneficial effects of cannabis use. Pre-clinical and clinical research has increasingly focused on the antiepileptic effectiveness of exogenous administration of cannabinoids and/or pharmacologically induced increase of eCBs such as anandamide (also known as arachidonoylethanolamide [AEA]). Concomitant research has uncovered the contribution of neuroinflammatory p…

0301 basic medicinemedicine.medical_treatmentFAAH inhibitorsPharmacologyeicosanoidslcsh:RC321-57103 medical and health scienceschemistry.chemical_compoundEpilepsyCellular and Molecular Neuroscience0302 clinical medicineFatty acid amide hydrolaseMedicineantiepileptic drugsPentylenetetrazolendocannabinoidsMolecular Biologypalmitoylethanolamidelcsh:Neurosciences. Biological psychiatry. NeuropsychiatryOriginal ResearchPalmitoylethanolamidebusiness.industryAnandamidemedicine.diseaseEndocannabinoid system030104 developmental biologyAnticonvulsantchemistryLC-MRMSystemic administrationlipidomicsepilepsybusiness030217 neurology & neurosurgerymedicine.drugNeuroscienceFrontiers in Molecular Neuroscience
researchProduct

Organized Sport Participation and Physical Activity Levels among Adolescents with Functional Limitations

2017

Sufficient and regular physical activity is considered a protective factor, reducing the onset of secondary disability conditions in adolescents with chronic diseases and functional limitations. The aim of this study was to explore whether participation in organized sport may be associated to higher levels of physical activity in adolescents with functional limitations, based on a national representative sample. Data from the Health Behaviour in School-aged Children (HBSC) study collected in Finland from two data collection rounds (2002 and 2010) were conducted and pooled from adolescents aged between 13 and 15 years old with functional limitations (n = 1041). Differences in self-reported p…

GerontologyInternational Classification of Functioning Disability and Health ICFPopulationVisual impairmentInternational Classification of Functioning Disability and Health (ICF)Protective factorPhysical activityvisual impairmentfyysinen toimintakykyPhysical Therapy Sports Therapy and RehabilitationInternational Classification of FunctioningArticleDevelopmental psychology03 medical and health scienceslcsh:GV557-1198.9950302 clinical medicinemedicinesalutogeneesiOrthopedics and Sports Medicine030212 general & internal medicineeducationta315krooniset tauditsalutogenesis; chronic disease; epilepsy; visual impairment; International Classification of Functioning Disability and Health ICF; generalized resistance resourceslcsh:Sportseducation.field_of_studyHealth behaviourta3141030229 sport sciencesSalutogenesisChronic diseasegeneralized resistance resourcesepilepsysalutogenesismedicine.symptomPsychologychronic diseaseepilepsiaDisability and Health ICF
researchProduct

Absence Seizure Detection Algorithm for Portable EEG Devices

2021

Absence seizures are generalized nonmotor epileptic seizures with abrupt onset and termination. Transient impairment of consciousness and spike-slow wave discharges (SWDs) in EEG are their characteristic manifestations. This type of seizure is severe in two common pediatric syndromes: childhood (CAE) and juvenile (JAE) absence epilepsy. The appearance of low-cost, portable EEG devices has paved the way for long-term, remote monitoring of CAE and JAE patients. The potential benefits of this kind of monitoring include facilitating diagnosis, personalized drug titration, and determining the duration of pharmacotherapy. Herein, we present a novel absence detection algorithm based on the propert…

Electroencephalographyportable devicewavelets03 medical and health sciencesEpilepsy0302 clinical medicineChildhood absence epilepsymedicineEEGRC346-429Portable EEG030304 developmental biology0303 health sciencesmedicine.diagnostic_testdetectorbusiness.industryBrief Research Reportmedicine.diseaseAbsence seizureNeurologySeizure detectionchildhood absence epilepsyFalse detectionAbrupt onsetNeurology. Diseases of the nervous systemNeurology (clinical)businessAlgorithm030217 neurology & neurosurgeryFrontiers in Neurology
researchProduct